Fast, accurate & proven automated brain image analysis.
NeuroQuant provides neurologists, radiologists, neuroradiologists and clinical researchers quantitative measurements from MRI brain studies that can be used in conjunction with other clinical findings as part of their clinical assessment. NeuroQuant should not be used as a stand-alone diagnostic tool.
NeuroQuant is intended for automatic labeling, visualization and volumetric quantification of segmentable brain structures from a set of MR images. This software is intended to automate the current manual process of identifying, labeling and quantifying the volume of segmentable brain structures identified on MR images.
Perform ongoing evaluations over time to track rate of atrophy with longitudinal studies, indicated on the same report.
A unique, patented technology:
The CorTechs Labs brain volume results with healthy cohorts is based on age and gender has been an integral part of the FDA cleared NeuroQuant solution.
In just a few minutes, with no user intervention, NeuroQuant
Yes, NeuroQuant is FDA cleared (2006), CE marked (2014), and Health Canada licensed (2016).
Yes, NeuroQuant can now be integrated with PowerScribe® 360 to streamline dictation of NeuroQuant results.
PowerScribe 360 integration works with both cloud based and locally installed NeuroQuant 2.0 systems.
NeuroQuant has been cleared for marketing as a medical device by the US FDA [510(k) K061855]. Analysis performed with NeuroQuant may be appropriate for billing under existing CPT code for 3D volumetric image post-processing (76377).
To meet our users’ unique needs, we offer an easy to access, cloud-based online solution as well as an onsite, locally installed solution.
A color overlay of the 3D MR series enabling closer inspection on a PACS or other DICOM
Data is easily exported to a CSV file for research need